Table 3.
Stratification analysis by clinical-pathological parameters in breast cancer patients.
| Parameters | GA + AA Cases/Controls 1 | GG Cases/Controls 2 | OR Adjusted (95% CI) | p 3 |
|---|---|---|---|---|
| Age | ||||
| <55 (mean) | 21 | 17 | 1.13 (0.55–2.31) | 0.857 |
| ≥55 (mean) | 23 | 18 | 0.91 (0.44–1.87) | 0.854 |
| Tumor site | ||||
| Ductal | 21 | 13 | 1.15 (0.52–2.52) | 0.843 |
| Lobular | 1 | - | - | 1.000 |
| Lymphovascular invasion | ||||
| Positive | 24 | 16 | 1.07 (0.51–2.22) | 1.000 |
| Negative | 13 | 12 | 0.77 (0.32–1.84) | 0.656 |
| RP | ||||
| Positive | 21 | 13 | 1.15 (0.52–2.52) | 0.843 |
| Negative | 6 | 5 | 0.85 (0.25–2.96) | 1.000 |
| RE | ||||
| Positive | 22 | 13 | 1.21 (0.55–2.63) | 0.697 |
| Negative | 9 | 3 | 2.13 (0.55–8.32) | 0.359 |
| HER2 | ||||
| Positive | 10 | 9 | 0.79 (0.29–2.09) | 0.803 |
| Negative | 20 | 8 | 1.78 (0.72–4.38) | 0.280 |
| Histological grade | ||||
| Grade I | 4 | 4 | 0.71 (0.17–2.99) | 0.720 |
| Grade II | 26 | 18 | 1.02 (0.51–2.08) | 1.000 |
| Grade III | 13 | 10 | 0.92 (0.37–2.28) | 1.000 |
| Menopausal period | ||||
| Premenopausal | 12 | 14 | 0.61 (0.26–1.44) | 0.280 |
| Postmenopausal | 24 | 17 | 1.01 (0.48–2.07) | 1.000 |
1 Controls: GA + AA = 66; 2 Controls: GG = 47; 3 Adjustment obtained in logistic regression models.